EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

The Effect of Curcumin on Reducing Atherogenic Risks in Obese Patients with Type 2 Diabetes: A Randomized Controlled Trial

Metha Yaikwawong, Laddawan Jansarikit, Siwanon Jirawatnotai, Somlak Chuengsamarn iD

Nutrients · 26.07.2024 · 16 (15) · 2441

DOI: 10.3390/nu16152441 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, online erschienen am 26.07.2024. Verfasst von Metha Yaikwawong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Curcumin, Obesity, Atherosclerosis. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Thailand Research Fund, Thai Traditional Medical Knowledge Fund, Thai Traditional Medical Knowledge Fund, Ministry of Public Health, Thailand.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Curcumin, derived from turmeric root, exhibits notable anti-inflammatory effects. These anti-inflammatory properties might also provide advantages in reducing cardiovascular complications, such as atherosclerosis. This study aimed to evaluate the efficacy of curcumin in reducing the risk of atherogenesis in obese patients with type 2 diabetes. The study employed a randomized, double-blind, placebo-controlled trial design with 227 participants diagnosed with type 2 diabetes. The parameters used to assess atherogenic risk reduction included pulse wave velocity and metabolic profiles, including low-density lipoprotein cholesterol and small dense low-density lipoprotein cholesterol. Measurements were recorded at baseline and at 3-, 6-, 9-, and 12-month intervals. After 12 months, participants receiving curcumin exhibited a significant reduction in pulse wave velocity (p < 0.001). This group showed significantly reduced levels of cardiometabolic risk biomarkers, including low-density lipoprotein cholesterol and small dense low-density lipoprotein cholesterol, all with p values less than 0.001. High-sensitivity C-reactive protein, interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha were also significantly lower in the curcumin group, with p values less than 0.001. The curcumin intervention significantly reduced pulse wave velocity and improved cardiometabolic risk profiles. These findings suggest that curcumin treatment may effectively reduce atherogenic risks in type 2 diabetes patients with obesity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2CurcuminObesityAtherosclerosisHumansMaleFemaleDouble-Blind MethodMiddle AgedBiomarkersAdultPulse Wave AnalysisC-Reactive ProteinCholesterol, LDL

Stichwörter der Autor:innen

atherogenic riskcardiometabolic riskscurcuminobesitytype 2 diabetes

Substanzen

CurcuminBiomarkersC-Reactive ProteinCholesterol, LDL

Autor:innen und Institutionen

  • Department of Pharmacology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
  • Siriraj Center of Research Excellence for Precision Medicine and Systems Pharmacology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
  • Faculty of Pharmacy, Silpakorn University, Nakhon Prathom 73000, Thailand.
  • Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine, HRH Princess Maha Chakri Sirindhorn Medical Center, Srinakharinwirot University, Nakhon Nayok 26120, Thailand.

ORCID-Profile: Somlak Chuengsamarn

Förderung

  • Thailand Research Fund
  • Thai Traditional Medical Knowledge Fund
  • Thai Traditional Medical Knowledge Fund, Ministry of Public Health, Thailand

Zitieren

APA

Yaikwawong, M., Jansarikit, L., Jirawatnotai, S., & Chuengsamarn, S. (2024). The Effect of Curcumin on Reducing Atherogenic Risks in Obese Patients with Type 2 Diabetes: A Randomized Controlled Trial. Nutrients, 16(15), 2441. https://doi.org/10.3390/nu16152441

Vancouver

Yaikwawong M, Jansarikit L, Jirawatnotai S, Chuengsamarn S. The Effect of Curcumin on Reducing Atherogenic Risks in Obese Patients with Type 2 Diabetes: A Randomized Controlled Trial. Nutrients. 2024;16(15):2441. doi:10.3390/nu16152441

BibTeX
@article{Yaikwawong2024,
  author = {Yaikwawong, Metha and Jansarikit, Laddawan and Jirawatnotai, Siwanon and Chuengsamarn, Somlak},
  title = {The Effect of Curcumin on Reducing Atherogenic Risks in Obese Patients with Type 2 Diabetes: A Randomized Controlled Trial},
  journal = {Nutrients},
  year = {2024},
  volume = {16},
  number = {15},
  pages = {2441},
  doi = {10.3390/nu16152441}
}
Kostenlos starten →